In conclusion, we have successfully utilized clinically well-annotated, uniformly treated patient samples using DNA from archival material greater than 20 years old without a matched normal to explore the prognostic effects encoded by the mutational landscape of ER+ breast cancer. Here, ESR1 is linked to breast carcinoma.